期刊文献+

针刺配合胃复春治疗胃黏膜不典型增生疗效观察 被引量:4

Observations on the Efficacy of Acupuncture plus Weifuchun Tablets in Treating Atypical Hyperplasia of Gastric Mucosa
下载PDF
导出
摘要 目的了解胃黏膜不典型增生组织诱导型一氧化氮合酶(iNOS)的表达水平,并观察针刺与胃复春综合治疗效果。方法将42例经胃镜病理学检查证实为中重度胃黏膜不典型增生的患者在治疗前采用S-P免疫组化法检测胃黏膜组织上iNOS的表达水平,于针刺联合胃复春口服治疗3个月后复查。结果与治疗前相比,iNOS在黏膜组织上的表达明显下降(P<0.01);HP转阴率有明显变化。结论 iNOS在胃黏膜不典型增生的过程中起了重要作用,针刺配合胃复春治疗对胃黏膜不典型增生者有明显保护作用。 Objective To know the level of inducible nitric oxide synthase(iNOS) expression in atypical hyperplasic gastric mucosa and investigate the effect of combined treatment with acupuncture and Weifuchun tablets.Methods The level of inducible nitric oxide synthase(iNOS) expression in gastric mucosa was examined by S-P immunohistochemical method before treatment and reexamined after 3 months’ combined treatment with acupuncture and Weifuchun tablets in 42 patients with moderate or severe atypical hyperplasia of gastric mucosa diagnosed by gastroscopic biopsy.Results Mucosal iNOS expression decreased significantly compared with before treatment(P0.01).The biopsy showed that atypical hyperplasia of gastric mucosa was markedly reduced.Conclusion Treatment with acupuncture plus Weifuchun tablets has a marked protecting effect against atypical hyperplasia of gastric mucosa.
机构地区 湖北省中山医院
出处 《上海针灸杂志》 2010年第8期501-502,共2页 Shanghai Journal of Acupuncture and Moxibustion
关键词 针刺 针药并用 胃炎 萎缩性 胃黏膜不典型增生 诱导型一氧化氮合酶 Acupuncture Combined use of acupuncture and medicine Gastritis atrophic Atypical hyperplasia of gastric mucosa Inducible nitric oxide synthase
  • 相关文献

参考文献5

二级参考文献37

  • 1陈望忠.两种新的选择性环氧合酶-2抑制剂[J].国外医学(药学分册),1997,24(3):168-171. 被引量:38
  • 2Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-1181.
  • 3Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, Leung WK, Ng EK, Lau JY, Lee YT, Yeung CK, Chao W, Chung SC.Atrophy and intestinal metaplasia one year after cure of H pylori infection:a prospective, randomized study. Gastroenterology 2000;119:7-14.
  • 4Schenk BE, Kuipers EJ, Nelis GF, Bloemena E, Thijs JC, Snel P,Luckers AE, Klinkenberg-Knol EC. Festen H pylori, Viergever PP, Lindeman J, Meuwissen SG. Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut 2000;46:615-621.
  • 5Gisbert JP, Blanco M, Pajares JM. Effect of Helicobacter pylori eradication on histological lesions of gastric mucosa. An 18-month follow-up study. Rev Clin Esp 2000;200:480-484.
  • 6Basso D, Gallo N, Zambon CF, Baron M, Navaglia F, Stockreiter E, Di Mario F, Rugge M, Plebani M. Antigastric autoantibodies in Helicobacter pylori infection: role in gastric mucosal inflammation. Int J Clin Lab Res 2000;30:173-178.
  • 7Ruiz B, Garay J, Correa P, Fontham ET, Bravo JC, Bravo LE, Realpe JL, Mera R. Morphometric evaluation of gastric antral atrophy:improvement after cure of Helicobacter pylori infection. Am J Gastroenterol 2001;96:3281-3287.
  • 8Perri F, Qasim A, Marras L, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2003;8(Suppl 1):53-60.
  • 9Mones J, Rodrigo L, Sancho F, Martin L, Boixeda D, Artes MT, Garcia-Cases C. Helicobacter pylori eradication versus one-year maintenance therapy:effect on relapse and gastritis outcome. Rev Esp Enferm Dig 2001;93:372-389.
  • 10McColl KE, el-Omar EM, Gillen D. Alterations in gastric physiology in Helicobacter pylori infection:causes of different diseases or all epiphenomena? Ital J Gastroenterol Hepatol 1997;29:459-464.

共引文献104

同被引文献59

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部